Literature DB >> 24806950

Rehospitalization risk of former voluntary and involuntary patients with schizophrenia.

Carmen Pfiffner1, Tilman Steinert, Reinhold Kilian, Thomas Becker, Karel Frasch, Gerhard Eschweiler, Gerhard Längle, Daniela Croissant, Wiltrud Schepp, Prisca Weiser, Susanne Jaeger.   

Abstract

BACKGROUND: The aim of the study was to examine the differences between former involuntary and voluntary patients with a schizophrenic disorder with regard to time to and frequency of rehospitalization.
METHODS: In this prospective observational study, 374 patients with a diagnosis of schizophrenia or schizoaffective disorder were included. At the time of inclusion, 290 (77.5 %) were hospitalized voluntarily and 84 (22.5 %) involuntarily. Follow-up assessments were conducted half-yearly over a 2-year period with measures of PANSS, GAF, sociodemographic data and cognitive functioning. These data served as covariates for adjustment in statistical models that included a Cox regression model, a random-effect logit model and a random-effect tobit model.
RESULTS: After adjustment for other relevant covariates, the Cox regression showed that involuntary treatment is a significant risk factor of subsequent rehospitalization (HR = 1.53; CI = 1.06, 2.19; p = 0.02). The involuntary group had higher half-year incidence rates of rehospitalization, and in case of rehospitalization the duration of hospital stay was longer.
CONCLUSIONS: Involuntary hospitalization seems to be associated with a higher risk of rehospitalization and longer subsequent hospital stays in patients with schizophrenia and schizoaffective disorders. Further studies are needed to examine in detail the processes and interventions that are suitable for interrupting circles of repeated hospitalizations, especially in former involuntary patients.

Entities:  

Mesh:

Year:  2014        PMID: 24806950     DOI: 10.1007/s00127-014-0892-2

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  43 in total

1.  The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation.

Authors:  S R Kay; L A Opler; J P Lindenmayer
Journal:  Br J Psychiatry Suppl       Date:  1989-11

2.  Why must some schizophrenic patients be involuntarily committed? The role of insight.

Authors:  J P McEvoy; P S Applebaum; L J Apperson; J L Geller; S Freter
Journal:  Compr Psychiatry       Date:  1989 Jan-Feb       Impact factor: 3.735

3.  Factors associated with readmission to a psychiatric facility.

Authors:  A C Bernardo; C Forchuk
Journal:  Psychiatr Serv       Date:  2001-08       Impact factor: 3.084

4.  Psychiatric status, quality of life, and level of care as predictors of outcomes of acute inpatient treatment.

Authors:  J Russo; P Roy-Byrne; C Jaffe; R Ries; C Dagadakis; D Avery
Journal:  Psychiatr Serv       Date:  1997-11       Impact factor: 3.084

5.  Neurobiology and the natural history of schizophrenia.

Authors:  Jeffrey A Lieberman
Journal:  J Clin Psychiatry       Date:  2006-10       Impact factor: 4.384

6.  Predictors of relapse in the year after hospital discharge among patients with schizophrenia.

Authors:  Rebecca Schennach; Michael Obermeier; Sebastian Meyer; Markus Jäger; Max Schmauss; Gerd Laux; Herbert Pfeiffer; Dieter Naber; Lutz G Schmidt; Wolfgang Gaebel; Joachim Klosterkötter; Isabella Heuser; Wolfgang Maier; Matthias R Lemke; Eckart Rüther; Stefan Klingberg; Markus Gastpar; Florian Seemüller; Hans-Jürgen Möller; Michael Riedel
Journal:  Psychiatr Serv       Date:  2012-01       Impact factor: 3.084

7.  Patients' revisions of their beliefs about the need for hospitalization.

Authors:  W Gardner; C W Lidz; S K Hoge; J Monahan; M M Eisenberg; N S Bennett; E P Mulvey; L H Roth
Journal:  Am J Psychiatry       Date:  1999-09       Impact factor: 18.112

8.  A 2-year follow-up of involuntary admission's influence upon adherence and outcome in first-episode psychosis.

Authors:  S Opjordsmoen; S Friis; I Melle; U Haahr; J O Johannessen; T K Larsen; J I Røssberg; B R Rund; E Simonsen; P Vaglum; T H McGlashan
Journal:  Acta Psychiatr Scand       Date:  2010-01-19       Impact factor: 6.392

9.  Compulsory admissions in a London borough: I. Social and clinical features and a follow-up.

Authors:  G I Szmukler; A S Bird; E J Button
Journal:  Psychol Med       Date:  1981-08       Impact factor: 7.723

Review 10.  Involuntary vs. voluntary hospital admission. A systematic literature review on outcome diversity.

Authors:  Thomas W Kallert; Matthias Glöckner; Matthias Schützwohl
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-06       Impact factor: 5.270

View more
  5 in total

1.  Risk factors for rehospitalization for patients following release from court-ordered evaluation: A retrospective study.

Authors:  Shabnam Sood; Gilbert Ramos; Nancy Van Der Veer; Curt Bay; B Rose Kaur; Amr Nasef; Napatkamon Ayutyanot
Journal:  Psychiatr Psychol Law       Date:  2020-04-20

2.  Association between the high-dose use of benzodiazepines and rehospitalization in patients with schizophrenia: a 2-year naturalistic study.

Authors:  Yukika Takita; Yoshikazu Takaesu; Kotaro Ono; Kunihiro Futenma; Akiyoshi Shimura; Akiko Murakoshi; Yoko Komada; Yuichi Inoue; Takeshi Inoue
Journal:  Neuropsychiatr Dis Treat       Date:  2016-12-15       Impact factor: 2.570

3.  Optimal Network for Patients with Severe Mental Illness: A Social Network Analysis.

Authors:  Vincent Lorant; James Nazroo; Pablo Nicaise
Journal:  Adm Policy Ment Health       Date:  2017-11

4.  Analysis of hospital costs by morbidity group for patients with severe mental illness.

Authors:  Vicent Caballer-Tarazona; Antonio Zúñiga-Lagares; Francisco Reyes-Santias
Journal:  Ann Med       Date:  2022-12       Impact factor: 4.709

5.  An intensive multimodal group programme for patients with psychotic disorders at risk of rehospitalization: a controlled intervention study.

Authors:  Mark H de Jong; André I Wierdsma; Arthur R Van Gool; Cornelis L Mulder
Journal:  BMC Psychiatry       Date:  2019-08-05       Impact factor: 3.630

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.